Doctors Warn or Reassure? The Mixed Messaging on Ivermectin in August 2025 The debate over Ivermectin USA in 2025 remains a contentious issue, stirring significant discussion among healthcare professionals, media, and the general public. Once celebrated primarily as an anti-parasitic drug, Ivermectin’s potential repurposing has sparked a firestorm of mixed messages. This divide is sowing confusion and uncertainty for patients seeking clear guidance....
0 Shares
312 Views
0 Reviews